Search Results 521-530 of 11393 for anti-TNF drugs

1. Fam-trastuzumab deruxtecan-nxki (intravenous route) - Side effects & uses - Mayo Clinic

   ... anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for ...

2. Non Hodgkin Clinical Trials

   Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...

3. Mayo Clinic research supports targeted therapy to manage kidney complications, potentially enabling continuation of lifesaving immunotherapy

   That gave us a platform to test targeted treatment for kidney inflammation that blocks the inflammatory signal TNF-alpha — an approach already used clinically ...

4. Study Of The Safety, Pharmacokinetics And Efficacy Of EDO-S101, In Patients With Advanced Solid Tumors - Mayo Clinic

   Patients who are on treatment with drugs known to prolong the QT/QTc interval. Patients who are being treated with Valproic Acid for any of its indication ...

5. Myasthenia gravis - Diagnosis and treatment - Mayo Clinic

   A breakdown in the communication between nerves and muscles causes weakness and fatigue of muscles under your control.

6. A Study To Determine The Safety, Tolerability And Pharmacokinetics Of An Anti-PD-1 Monoclonal Antibody In Subjects With Advanced Malignancies - Mayo Clinic

   Clinical Trials · A Study To Determine The Safety, Tolerability And Pharmacokinetics Of An Anti-PD-1 Monoclonal Antibody In Subjects With Advanced Malignancies.

7. Mayo study identifies new potential treatment option for triple negative breast cancer

   ROCHESTER, Minn. — In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for ...

8. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

   A phase 1 study finds low incidence of severe side effects and high response rate for ide-cel, an anti-BCMA CAR-T cell therapy for relapsed or refractory ...

9. Comparison Of Anti-coagulation And Anti-Platelet Therapies For Intracranial Vascular Atherostenosis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... By condition, treatment or drug name. Search tips. Comparison Of Anti- ...

10. LY4268989 (MORF-057) Co-Administered With Mirikizumab In Adults With Moderately To Severely Active Ulcerative Colitis: - Mayo Clinic

    ... therapy for UC, defined as: * a biologic or biosimilar medication such as anti-tumor necrosis factor (anti-TNF) antibodies or anti-interleukin antibodies ...